Olfactory Disorder Clinical Trial
— ProspeRo'ScentOfficial title:
Prospective Registry of Outcome and Correlates of Chemosensory Dysfunction at the Smell & Taste Clinic of UZ Leuven
NCT number | NCT06456008 |
Other study ID # | S67158 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | December 6, 2022 |
Est. completion date | December 31, 2035 |
Smell/taste disorders are common conditions with a significant impact on quality of life. In September 2021, a specific consultation for patients with smell and taste disorders was initiated at the ENT-HNS (ear, nose, and throat, head and neck surgery) department of UZ Leuven, partly in light of post-COVID-19 related smell disorders. With this observational ambidirectional study, we aim to better map smell/taste disorders in the Belgian/Flemish population. Using standard-of-care diagnostic tests and structured questionnaires, we strive to gain more insight into the severity, impact, and progression/prognosis of smell/taste disorders.
Status | Recruiting |
Enrollment | 500 |
Est. completion date | December 31, 2035 |
Est. primary completion date | January 1, 2025 |
Accepts healthy volunteers | |
Gender | All |
Age group | N/A and older |
Eligibility | The psychophysical testing as well as the questionnaires require a cooperative participant who can understand and follow instructions and communicate their choices. Informed consent is necessary upon participation for prospective registry. There are no exclusion criteria related to sex, gender, or ethnicity. There are no exclusion criteria related to medical history or prior treatments. This study conveys no additional risks for care groups such as pregnant women, or elderly |
Country | Name | City | State |
---|---|---|---|
Belgium | UZ/KU Leuven | Leuven | Vlaams-Brabant |
Lead Sponsor | Collaborator |
---|---|
Universitaire Ziekenhuizen KU Leuven |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Chemosensory function | Observational up to 5 years follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04617444 -
The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function
|
N/A | |
Completed |
NCT02985515 -
Steroid Nasal Irrigation for Flavor Evaluation and Detection Study
|
N/A | |
Recruiting |
NCT06066307 -
Olfactory Performance in Culinary Arts Students
|
Phase 4 | |
Completed |
NCT05445921 -
Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction
|
Phase 1/Phase 2 | |
Recruiting |
NCT05855369 -
Smell Training and Trigeminal Nerve Stimulation for COVID-related Smell Loss
|
Phase 2/Phase 3 | |
Recruiting |
NCT03574701 -
Intranasal Retinoic Acid Treatment for Patients With OlfactoryLOSS: A RANDOMIZED CONTROLLED TRIAL
|
N/A | |
Enrolling by invitation |
NCT04764981 -
Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19)
|
N/A | |
Completed |
NCT03990766 -
Smell Changes & Efficacy of Nasal Theophylline
|
Phase 2 | |
Withdrawn |
NCT05542095 -
Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
|
Phase 1 | |
Recruiting |
NCT04791436 -
Oral and Olfactory Complications of Recovered COVID-19 Patients
|
||
Enrolling by invitation |
NCT05038475 -
Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19
|
||
Completed |
NCT01332825 -
cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose
|
N/A | |
Completed |
NCT04789499 -
Smell in Covid-19 and Efficacy of Nasal Theophylline
|
Phase 2 | |
Active, not recruiting |
NCT04761458 -
Correlation of Preoperative Global Olfactory Function With Frailty, Perioperative Neurocognitive Disorders and Mortality
|
N/A | |
Completed |
NCT04406584 -
Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction
|
N/A | |
Completed |
NCT03611673 -
At-Home Olfactory Training
|
N/A | |
Completed |
NCT04700891 -
Correlation of Preoperative Olfactory Identification Function With Frailty and Postoperative Complications and Mortality
|
N/A | |
Recruiting |
NCT04466982 -
Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection
|
||
Recruiting |
NCT04869436 -
Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis
|
Phase 4 | |
Recruiting |
NCT05448898 -
The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction
|
N/A |